During this unprecedented time, mental health is more important than ever. That’s why we are creating forums to tackle the most pressing, controversial topics in mental health. Talking about mental health issues is the first step towards erasing the stigma associated with it.
Through our webinars, our blog posts and other resources, we are working to raise awareness about the challenges in the mental health world.
Please check back often for new GeneSight Cares information.
We are bringing together leading healthcare experts for open discussions. These webinars create conversations that ask the hard questions, that provoke difficult discussions, and that ultimately will lead to better care for patients.
Depression and Addiction: The Connection and GeneSight’s Role
There is often a strong connection between addiction and mental illness: depression and anxiety may be the root causes of behavioral and substance addictions–and vice versa.
Underlying mental health conditions should be treated for patients suffering from addiction disorders to improve overall mental health. Yet, patients may not be willing to disclose their mental health or addiction concerns due to stigma. Not addressing a patient’s underlying depression may lead them to spiral even further out of control.
This GeneSight Cares webinar seeks to educate and inform clinicians that using the GeneSight test as a tool to help with the treatment of depression and anxiety in concurrence with an addiction disorder may lead to better outcomes.
Our goal is for attendees of this webinar to learn:
• Tactics to identify underlying depression and signs of addiction disorder
• When to use the GeneSight test once depression is identified
• Where the GeneSight test can be used to improve patient outcomes
Building Trust by Reducing Bias – GeneSight as a Tool for Mental Health Equity
Our panel of expert healthcare providers shared practical approaches for improving racial health equity in mental healthcare settings, including recent research presented at APA showing patients who received treatment guided by PGx testing showed improvements in clinical outcomes regardless of self-reported race or ethnicity.
Panelists included: – Gus Alva, MD, DFAPA – Founder and Medical Director, ATP Clinical Research in Costa Mesa, Calif. – Johnny Williamson, MD – Owner, Spectrum Behavioral Health in Hinsdale and New Lenox, Ill. – Morgan Saulsberry, PharmD – Senior Medical Science Liaison, Myriad Mental Health, Dallas, Texas
Are You Playing Offense or Defense With Your Patients’ Mental Health? Enhancing Your Treatment Playbook
Primary care providers (PCPs), like family practitioners, internists, social workers, OB-GYNs, advance practice nurses, and more are on the front lines of an escalating mental health crisis.
Our panel of experts explained how tools like the GeneSight test are helping PCPs improve mental healthcare for their patients.
It’s Time to Talk Suicide: Addressing Stigma Around a Difficult Topic
The Talk: Parenting Through Racism and its Impact on Mental Health
Coming Out as Hate Awaits – The Impact on LGBTQ+ Mental Health
Depression Disconnect: Building a Bridge to Understanding and Treatment
Inherited Mistrust: What’s Behind Black Skepticism of Mental Healthcare?
A Flood of Patients Amid a Drought of Resources: Barriers to Access in Mental Health Care
Could Senior Moments be Depression? Understanding Nuances in Geriatric Depression Treatment
Does Unconscious Bias Affect Your Treatment of Black Patients?
Whether it’s in medical settings, on the street or in the classroom, unconscious bias exists all around us. And it is largely racial bias.
Our panel of board-certified psychiatrists shared stories of experiencing implicit and explicit bias; and offered participants the chance to learn strategies to address unconscious bias and stereotypes in healthcare settings.
LGBTQ+ and Depression: Addressing Double Stigma in Mental Healthcare
Patients who identify as lesbian, gay, bisexual, transgender, queer or questioning, and other gender and sexual orientations (LGBTQ+) can often experience a double stigma in which they feel they are not accepted by either the mental health community due to their LGBTQ+ identities or the LGBTQ+ community due to mental health issues including depression.
The mental health practitioners on our panel shared how simple actions and meaningful inclusion practices can help LGBTQ+ patients with depression feel more supported in clinical environments.
Depression and Addiction: The Connection and GeneSight’s Role
DECEMBER 6, 2022
Building Trust by Reducing Bias – GeneSight as a Tool for Mental Health Equity
JULY 27, 2022
Are You Playing Offense or Defense With Your Patients’ Mental Health? Enhancing Your Treatment Playbook
MARCH 1, 2022
It’s Time to Talk Suicide: Addressing Stigma Around a Difficult Topic
SEPTEMBER 28, 2021
The Talk: Parenting Through Racism and its Impact on Mental Health
JULY 29, 2021
Coming Out as Hate Awaits – The Impact on LGBTQ+ Mental Health
JUNE 25, 2021
Depression Disconnect: Building a Bridge to Understanding and Treatment
MAY 19, 2021
Inherited Mistrust: What’s Behind Black Skepticism of Mental Healthcare?
FEBRUARY 25, 2021
A Flood of Patients Amid a Drought of Resources: Barriers to Access in Mental Health Care
NOVEMBER 19, 2020
Could Senior Moments be Depression? Understanding Nuances in Geriatric Depression Treatment
SEPTEMBER 23, 2020
Does Unconscious Bias Affect Your Treatment of Black Patients?
AUGUST 10, 2020
LGTBQ+ and Depression: Addressing Double Stigma in Mental Healthcare
AUGUST 5, 2020
Find out about upcoming webinars, share an idea about a topic, or participate on a panel.
Caring About Mental Health
Our collective mental health has taken a hit. We are grieving, struggling with uncertainty, and limited in sources for solace.
LGBTQ+ & Mental Health
It’s important for anyone struggling with depression to seek treatment, especially in the LGBTQ+ community.
GeneSight Blog
Here, we share our learnings, insights, research and stories to bring awareness to the topic of depression.
This story is one patient or healthcare provider’s personal experience with GeneSight. Others may not have the same experience or outcome. Do not make any changes to your current medications or dosing without consulting your healthcare provider. The GeneSight test must be ordered by and used only in consultation with a healthcare provider who can prescribe medications.